COLM
Columbia Sportswear Company
COLM has the edge over RIVN overall, supported by lower modeled downside and stronger valuation.
RIVN
Rivian Automotive, Inc.
RIVN's outlook is improving, though it still trails on the overall score.
COLM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
COLM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
COLM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $69.30 | -3.3% |
| Current | 16x | $71.64 | — |
| Forward | 17x | $71.64 | — |
| Fair | 18x | $83.30 | +16% |
| Expensive | 26x | $117 | +63% |
Historical ranges are pointers, not guarantees.
COLM's PE is in its cheap range at 16x. On analysts' estimates for next year's earnings, today's price would be 17x.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
COLM Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for COLM, with profitability improving.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
COLM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | -4.8% |
| Q3 2026 | $4.56 | +40% |
| Q2 2026 | $3.85 | -0.5% |
| Q1 2026 | $3.14 | -19% |
| Q4 2025 | $3.24 | -15% |
| Q3 2025 | $3.26 | -8.9% |
| Q2 2025 | $3.87 | +4% |
| Q1 2025 | $3.86 | -4.9% |
| Q4 2024 | $3.82 | -6.6% |
COLM has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
COLM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $962.6M | +2% |
| Q2 2026 | $614.4M | +1.5% |
| Q1 2026 | $779M | +0.1% |
| Q4 2025 | $1.1B | -2.4% |
| Q3 2025 | $943.4M | +1.3% |
| Q2 2025 | $605.2M | +6.1% |
| Q1 2025 | $778.5M | +1.1% |
| Q4 2024 | $1.1B | +3.5% |
COLM's revenue fell from its 2022 peak and has held roughly level since: $963M last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +4.3 points |
| Q2 2026 | 5% | +8.9 points |
| Q1 2026 | 5.4% | -0.6 points |
| Q4 2025 | 11% | -1.6 points |
| Q3 2025 | 7.1% | -4.9 points |
| Q2 2025 | -3.9% | +0.3 points |
| Q1 2025 | 6% | +0.2 points |
| Q4 2024 | 13% | +1.8 points |
COLM has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over COLM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
COLM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$333M | -$45.8M |
| Q2 2026 | $101.6M | +$147M |
| Q1 2026 | -$90M | -$42.4M |
| Q4 2025 | $596.8M | +8.6% |
| Q3 2025 | -$287.2M | -$87.7M |
| Q2 2025 | -$45.3M | -$34.4M |
| Q1 2025 | -$47.6M | -152% |
| Q4 2024 | $549.6M | -8.5% |
COLM has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
COLM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -318K shares |
| 1 year | -6.6% | -3.6M shares |
| 3 years | -16% | -10M shares |
| 5 years | -23% | -15.3M shares |
| Available history | -26% | -17.5M shares |
COLM has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50M |
| Q2 2026 | — |
| Q1 2026 | $150M |
| Q4 2025 | $29.4M |
| Q3 2025 | $40M |
| Q2 2025 | $30.3M |
| Q1 2025 | $101.4M |
| Q4 2024 | $86.9M |
COLM spent $229M buying back its own shares over the past year, down 11% from the year before.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
COLM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
COLM has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
COLM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 92.5 | Overbought |
COLM's weekly RSI is 71 (overbought) and its Stochastic is 93 (overbought).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
COLM PE vs Consumer Cyclical Sector
| Metric | COLM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 13% below |
| PE % | 21 | 47 | 26 pts below |
COLM is trading at 16x earnings, a 13% discount to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
COLM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 14% above |
| 20 week MA | $61.0 | 18% above |
| 50 week MA | $60.0 | 19% above |
| 100 week MA | $62.8 | 14% above |
| 200 week MA | $71.6 | 0.1% above |
COLM has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
COLM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $99.7 | $90.2 | -9.5% |
| 2021 | $90.2 | $93.8 | +4% |
| 2022 | $93.8 | $85.9 | -8.4% |
| 2023 | $85.9 | $79.5 | -7.4% |
| 2024 | $79.5 | $85.8 | +7.8% |
| 2025 | $85.8 | $55.6 | -35% |
| 2026 YTD | $55.6 | $71.6 | +29% |
COLM has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.